Skip to main content

Advertisement

Role of Helicobacter pylori cagA EPIYA motif and vacAgenotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis

BMC Infectious Diseases volume 12, Article number: 223 (2012) Cite this article

Article metrics

Abstract

Background

Infection with cagA-positive, cagA EPIYA motif ABD type, and vacA s1, m1, and i1 genotype strains of Helicobacter pylori is associated with an exacerbated inflammatory response and increased risk of gastroduodenal diseases. However, it is unclear whether the prevalence and virulence factor genotypes found in Southeast Asia are similar to those in Western countries. Here, we examined the cagA status and prevalence of cagA EPIYA motifs and vacA genotypes among H. pylori strains found in Southeast Asia and examined their association with gastroduodenal disease.

Methods

To determine the cagA status, cagA EPIYA motifs, and vacA genotypes of H. pylori, we conducted meta-analyses of 13 previous reports for 1,281 H. pylori strains detected from several Southeast Asian countries.

Results

The respective frequencies of cagA-positive and vacA s1, m1, and i1 genotypes among examined subjects were 93% (1,056/1,133), 98% (1,010/1,033), 58% (581/1,009), and 96% (248/259), respectively. Stratification showed significant variation in the frequencies of cagA status and vacA genotypes among countries and the individual races residing within each respective country. The frequency of the vacA m-region genotype in patients infected with East Asian-type strains differed significantly between the northern and southern areas of Vietnam (p < 0.001). Infection with vacA m1 type or cagA-positive strains was associated with an increased risk of peptic ulcer disease (odds ratio: 1.46, 95%CI: 1.01-2.12, p = 0.046 and 2.83, 1.50-5.34, p = 0.001, respectively) in the examined Southeast Asian populations.

Conclusions

Both Western- and East Asian-type strains of H. pylori are found in Southeast Asia and are predominantly cagA-positive and vacA s1 type. In Southeast Asia, patients infected with vacA m1 type or cagA-positive strains have an increased risk of peptic ulcer disease. Thus, testing for this genotype and the presence of cagA may have clinical usefulness.

Open Peer Review reports

Background

Helicobacter pylori infection is closely associated with the development of peptic ulcer disease and gastric cancer [1–4]. H. pylori colonizes the gastric mucosa of 50% of the world’s population, with infection levels exceeding 70% in developing areas, such as Latin America and Africa [5–10]. Several Southeast Asian countries also have a high prevalence of H. pylori infection, particularly Thailand, where the H. pylori infection rate ranges from 54.1%-76.1% [11, 12]. Therefore, developing countries, including those located in Southeast Asia, are considered to have a higher incidence of H. pylori-related diseases. However, the estimated age-standardized incidence rate of gastric cancer in Southeast Asian countries (10.2 and 4.7/100,000 in men and women, respectively) is lower than those in East Asia (e.g., 124.63/100,000 in Japan and 48.25/100,000 in Korea) and South America (e.g., 33.22/100,000 in Colombia) (http://globocan.iarc.fr/). This phenomenon, which is characterized by high levels of H. pylori infection, but a low incidence of gastric cancer, is referred to as the “Asian paradox” [13, 14].

Recently, numerous studies have examined the relationships between H. pylori virulence factors and outer membrane proteins with gastric mucosal inflammation and gastroduodenal disease development [9, 10, 15, 16]. The cag PAI including of cagA encodes a putative type IV secretion system, which transfers a variety of multimolecular complexes, such as CagA, and across the bacterial membrane to the extracellular space or into other attached host cells [17, 18]. H. pylori cagA plays important roles in gastric mucosal inflammation and injury in relation to activated inflammatory cells infiltration [19, 20]. Activated neutrophils and mononuclear cells infiltrating into gastric mucosa with H. pylori infection produce several pro-inflammatory cytokines (e.g., IL-1β, IL-6, IL-8 and TNF-α) and anti-inflammatory cytokines (e.g., IL-4 and IL-10). Greater than 90% of H. pylori strains isolated from East Asian populations carries the cagA gene [7, 21]. In contrast, 40% of strains isolated in Western countries are cagA-negative [7, 21]. Moreover, as tyrosine phosphorylation of CagA occurs at EPIYA sites consisting of five amino acid residues, the structure and role of the cagA EPIYA motif in cagA gene have been investigated [22–24]. The EPIYA motif exhibits genetic variation that occurs in four distinct segments, the EPIYA-A, -B, -C, and –D segments [22–24]. The representative CagA of Western H. pylori strains possesses a single EPIYA-A and EPIYA-B segment, followed by a 34-amino-acid EPIYA-C segment (EPIYA-ABC type). The C-terminal regions of East Asian and Western CagA are characterized by the presence of EPIYA-ABD and -ABC segments, respectively [22–24]. In addition, we [7] reported that H. pylori strains isolated from East Asian and Western countries could be completely distinguished by polymerase chain reaction-based cagA 5’ and 3’ region genotyping, and named the East Asian type H. pylori strains as cagA 1a type and the Western type H. pylori strains as cagA 2a type. CagA 1a type is correspondent roughly to Western-type cagA (EPIYA-ABC) genotype and 2a type to East Asian-type cagA (EPIYA-ABD) genotype. However, it is unclear whether the cagA EPIYA motif is associated with the development of gastrointestinal disease in Southeast Asian populations.

Gastric epithelial cell injury associated with H. pylori infections is caused by a vacuolating cytotoxin encoded by the H. pylori vacA gene. The vacA signal (s) region encodes the signal peptide and N-terminus of processed vacA toxin. In H. pylori, the vacA s1 genotype is associated with fully active toxin, but type 2 genotype strains produce vacA with a short N-terminal extension that blocks vacuole formation [25]. The vacA middle (m) region encodes part of the 55-KDa subunit located at the C-terminus and has two genotypes (m1 and m2); the former causes stronger vacuolating activities than the latter [25]. Recently, a third polymorphic determinant of vacuolating activity located between the s- and m- regions was identified and termed the intermediate (i) region [26]. In general, the vacA s1, m1, and i1 genotypes of H. pylori are associated with an increased risk of disease due to the enhanced production of toxin with markedly higher vacuolating activity than that of vacA s2, m2, and i2 genotype strains, which are rarely associated with peptic ulcer disease and gastric cancer [7, 8, 15, 25, 27–30]. However, it is unclear whether this association is observed in H. pylori strains commonly found in Southeast Asian populations.

To date, 13 studies have investigated the cagA status and genotyping of cagA EPIYA motifs and vacA s, m, and i-regions in H. pylori strains found among Southeast Asian populations (Table 1) [7, 31–42]. However, due to the small sample size in each report, it remains unclear whether cagA-positive strains and the EPIYA motif and vacA genotypes are associated with an increased risk for gastrointestinal disease in Southeast Asian populations [7, 31–42]. Therefore, the present study was designed to elucidate the relationship between H. pylori virulence-factor genotypes and H. pylori-related disease susceptibility in H. pylori-infected patients living in Southeast Asia.

Table 1 Reported cagA genotypes and vacA s, m, and i regions genotypes and cagA status in studies used in the present meta-analysis
Full size table

Methods

Study selection

A literature search was performed using the PubMed databases for articles written in English and published before June 2011. The following search words were used: 1) cagA or EPIYA, 2) vacA or vacuolating cytotoxin, 3) pylori or Helicobacter, and 4) genotype. We did not include abstracts or unpublished articles. We conducted a combined analysis to determine the prevalence of cagA-positive strains, cagA EPIYA motif genotypes, and vacA genotypes in H. pylori strains found in Southeast Asia and their association with gastrointestinal diseases.

Inclusion Criteria

The following criteria were applied to select published case–control studies examining the relationship between cagA EPIYA motif genotype or vacA genotype and clinical outcomes in adult populations infected with H. pylori isolated in four Southeast Asian countries (Vietnam, Thailand, Singapore, and Malaysia): the presence and genotypes of the cagA EPIYA motif (ABC, ABCC, and ABD genotypes) and vacA (vacA s-, m-, and i- regions) were examined by polymerase chain reaction (PCR) and original articles published in English. The references cited in these manuscripts were also screened using the same inclusion criteria. When it appeared that the same subjects were included in multiple reports, only the earliest article was selected.

Data analysis

As several studies did not measure all parameters simultaneously (cagA status and vacA s-, m-, and i-region genotypes), the patient and strain numbers (H. pylori genotype number) did not match in the following analyses.

Statistical differences in the prevalence of cagA status, EPIYA motif genotype, and vacA genotype among the individual countries and ethnic groups were determined by the chi-squared test and Fisher's exact test. The effects of cagA status, EPIYA motif genotype, and vacA genotypes on the risk of gastric cancer and peptic ulcer disease were expressed as odds ratios (ORs) with 95% confidence intervals (CIs) with reference to non-ulcer dyspepsia (NUD) subjects infected with H. pylori. NUD was defined as endoscopical gastritis with no peptic ulcer disease or gastric cancer. In this study, patients with ‘NUD’ were regarded as the control group. All p values were two-sided, and p values <0.05 were considered statistically significant. Calculations were carried out using the statistical software StatView 5.0 (SAS Institute, Cary, NC, USA). Meta-analyses were performed using Comprehensive Meta-Analysis software (version 2, Biostat, Englewood, NJ).

Results

Included studies

Seventeen studies investigating Southeast Asian populations were identified using our search criteria (Table 1). Notably, a report from Yamaoka et al. [7] included two populations: Vietnamese and Thai. Van Doorn et al.[43] included strains isolated from Southeast Asia, but did not report the country of origin. Studies by Ho et al. [44] and Vivatvakin et al. [45] did not provide detailed vacA genotype information, and a report from Yamaoka Y et al. [46] investigated Vietnamese living in Houston, Texas. Finally, a total of 13 studies with a combined 1,281 patients (4 reports for Vietnam, 4 from Thailand, 5 from Malaysia, and 1 from Singapore) were included in the systematic analyses (Tables 1 and 2).

Table 2 Summary of cagA status , EPIYA motif genotype, and vacA s-, m- and i-region genotypes in different Southeast Asian countries
Full size table

Prevalence of cagA and vacAs, m, and i-region genotypes

In H. pylori strains isolated from Southeast Asia, the respective frequencies of vacA s1, m1, and i1 genotypes among the examined subjects were 98% (1,010/1,033), 58% (581/1,009), and 96% (248/259). The prevalence of the vacA m-region and combined vacA s/m genotypes differed significantly among isolates from the various Southeast Asian countries (p < 0.001) (Table 2 and Figure 1). However, no significant difference between the prevalence of vacA s-region genotypes was detected. The frequency of the vacA s2m1 combination genotype was close to 0%, which was in agreement with most previous studies examining other geographical regions [9, 25]. Interestingly, the frequency of sub-genotypes of vacA s1, s1a and s1c, which are reported to be specific for East Asian H. pylori strains [7], were similar in Thailand and Malaysia (Table 2). Reports from Nguyen TL, et al. [33] and Schmidt HMA, et al. [41] investigated vacA i-region genotypes; however, the correlation with vacA i-region genotypes at the population level was unclear.

Figure 1
figure1

Proportion of vacA s, m, and i genotypes and cagA status among H. pylori strains isolated from different Southeast Asia populations. The frequencies of vacA m region genotype, but not vacA s and i region genotypes or cagA status, significantly differed among the examined Southeast Asia countries

Full size image

Of the 13 included studies, 93% of H. pylori strains were cagA positive. The strains were divided into the following two groups: East Asian strains, including the EPIYA-ABD genotype [22] and 1a type according to PCR-based cagA 5’ and 3’ region genotyping [7], and Western-type strains, including EPIYA-ABC and -ABCC genotypes and 2a type. The prevalence of East Asian- and Western-strain type cagA was 65% and 35%, respectively. In the Vietnam population, 97% (139/144) of strains was East-Asian strain type cagA, whereas H. pylori strains in Thailand and Malaysia consisted of approximately half of East Asian- and Western-type strains (Table 2).

Three studies compared H. pylori strains isolated from the northern (Hanoi) and southern parts (Ho Chi Minh) of Vietnam [31–33] (Tables 1 and 3). Although the prevalence of the vacA s1 genotype was identical between both areas (100%), the vacA m1 genotype was found at a significantly higher frequency in strains isolated from the north (58%; 60/104) than from strains detected in the south (34%, 32/94; p = 0.001). Therefore, the virulence of H. pylori in Vietnam may differ between the northern and southern areas of the country, despite having the same native population.

Table 3 Differences in the distribution of cagA and vacA genotypes among different races residing within the same country
Full size table

Thailand and Malaysia consist of individuals from neighboring populations. In Thailand, although the prevalence of the vacA m1 genotype was higher (64%) than that of the m2 genotype (36%), vacA m-region genotypes differed among Thai, Thai-Chinese, and Chinese populations. The prevalence of the vacA m1 genotype among native Thai, who represent the majority of the population (approximately 75%), was 92%, which was significantly higher than that in Chinese (40%, p < 0.001) (Table 3). In the analysis of the vacA s1 subtype, most strains isolated from Chinese patients were the s1c subtype (75%), which was significantly higher than that found in Thai and Thai-Chinese patients (p < 0.001). Moreover, the cagA EPIYA motif genotype significantly differed among the examined geographic populations (p < 0.001). Although East Asian-type cagA was predominant in Chinese living in Thailand, Western-type cagA was predominant in Thai patients, suggesting that most native Thai living in Thailand are infected with Western-type H. pylori. Therefore, this observation suggests that although H. pylori infections in Thai are predominantly due to vacA s1m1 type strains, which have high virulence, the strains possess Western-type cagA, which is associated with weak virulence compared with East Asian strains [47].

In Malaysia, the prevalence of vacA m1 genotypes was similar among Malay (64%), Chinese (55%), and Indian (70%) patients (p = 0.065) (Table 3). Most strains isolated from Indian and Malay patients were of the s1a subtype (82% and 92%, respectively). In the analysis of cagA EPIYA genotype, Chinese patients were predominantly infected with East Asian-type cagA (EPIYA-ABD), whereas Indian patients were mostly infected with Western-type cagA (EPIYA-ABC). The incidence of Western-type cagA was slightly higher in Malay patients, who formed the majority of the population. The examination of strains isolated from different ethnic groups provided an opportunity to examine the hypothesis that ethnic groups tend to retain their ancestral H. pylori genotype after migration [7, 46]. Intermarriage among ethnic Thai and Chinese in Thailand also allowed examination of the transmission pathways in relation to the ethnic status of the parents. When the mother was Chinese, 84% of the offspring possessed H. pylori with an East Asian genotype. By contrast, when mother was Thai and father Chinese, only 29% of strains among offspring were of East Asian types. This finding is consistent with the notion that the primary caretaker of the children is the most likely source of infection. Taken together, these observations suggest that the susceptibility of different geographic populations to H. pylori strains and H. pylori-associated disease differed.

Risk of gastric cancer and peptic ulcer disease development associated with cagA status and vacAs, m, and i genotypes

Of the 13 examined studies, 6 investigated the associations between gastroduodenal diseases and vacA s- and m-region genotypes [33, 35–37, 41, 42], and 2 investigated disease associations based on the vacA i-region genotype [33, 41].

Nguyen et al. [33] reported that the frequency of vacA m1 alleles among H.pylori strains isolated from patients with peptic ulcer disease was 71% (17/24) in Vietnam, but only 41% with NUD (31/76; p = 0.146), although the difference was not significant. However, in combined analysis using Southeast Asian strains, the frequencies of vacA s1, m1, and i1 genotypes in H. pylori-infected NUD were 99%, 55%, and 94%, respectively, which were similar frequencies to those found in patients with peptic ulcer disease (100%, 59%, and 100%, respectively) and gastric cancer (100%, 54% and 100%, respectively) (Table 4). In meta-analysis, infection with vacA m1 type strains increased the risk of peptic ulcer development (OR: 1.46, 95%CI: 1.01-2.12, p = 0.046) in the Southeast Asian population (Figure 2A). However, the vacA s1 and i1 genotypes were not associated with an increased risk of either peptic ulcer disease or gastric cancer.

Table 4 Summary of cagA and vacA s, m, and i genotypes in relation to peptic ulcer disease and gastric cancer risk
Full size table
Figure 2
figure2

Results of the meta-analysis for the risk of peptic ulcer disease in infections associated with vacA m1 genotype (A) and cagA -positive (B) H. pylori strains

Full size image

Eight studies investigated the association between gastroduodenal disease and cagA status [32, 33, 35–37, 41, 42], while four reported the relationship between disease and cagA type [32, 39–41]. In the meta-analysis, infection with cagA-positive strains increased the risk of peptic ulcer disease (OR: 2.83, 95%CI: 1.50-5.34, p = 0.001) in Southeast Asian populations. Schmidt et al. [40] reported that among Chinese patients with gastric cancer, the prevalence of EPIYA-ABD, -ABCC, and -ABC motif genotypes was 85.7%, 14.3%, and 0%, respectively. Moreover, these same authors later reported that the prevalence of the EPIYA-ABC and -ABD genotypes in Malaysia were 52.5% and 47.5% in patients with NUD, 13.6% and 86.4% with gastric cancer, and 31.3% and 68.7% with duodenal ulcer, respectively. The occurrence of East Asian-type strain (EPIYA-ABD) was higher in patients with peptic ulcer disease and gastric cancer than in those infected with Western-type strain (EPIYA-ABC) (Table 4). The prevalence of Western-type strain (EPIYA-ABC) in patients with NUD, peptic ulcer disease, and gastric cancer were 44% (127/287), 21% (11/53), and 17% (9/55), respectively, and 56%, 79%, and 83%, respectively, for East Asian-type strain (EPIYA-ABD). The risk of gastric cancer and peptic ulcer disease development in patients infected with East Asian-type strain (EPIYA-ABD) was significantly increased (OR: 3.03, 95%CI: 1.50-6.13, p < 0.002 and OR: 3.97, 95%CI: 1.87-8.43, p < 0.001, respectively).

Discussion

Highly virulent genotypes of H. pylori are associated with gastric epithelial damage, including gastric mucosal atrophy, in infected patients [30]. Notably, the vacA s1, m1, and i1 genotypes and cagA-positive strains of H. pylori are linked to elevated inflammatory cell infiltration compared to that induced by vacA s2, m2, and i2 genotypes and cagA-negative strains [48, 49]. In the present study, our meta-analyses revealed a significant relationship between H. pylori virulence factor-associated genotypes, particularly vacA m-region genotype and cagA status, and an increased risk for the development of peptic ulcer disease in Southeast Asian populations.

An important characteristic of Southeast Asian countries is that several geographic populations live together. Recently, Breurec et al. [50] reported that five major types of historical human migration patterns have occurred in Southeast Asia: i) migration from India introducing hpEurope bacteria into Thailand, Cambodia, and Malaysia; ii) migration of the ancestors of Austro-Asiatic speaking people carrying hspEAsia bacteria into Vietnam and Cambodia; and iii) migration of the ancestors of the Thai people from Southern China into Thailand carrying H. pylori of population hpAsia2; iv) migration of Chinese to Thailand and Malaysia within the last 200 years resulting in the spread of hspEAsia strains; and v) migration of Indians to Malaysia within the last 200 years distributing both hpAsia2 and hpEurope bacteria. Therefore, both Western and East Asian strains according to EPIYA motif genotyping can be observed in Southeast Asia. East Asian-type strain (EPIYA-ABD) was associated with an approximately three-fold increased risk of disease. Therefore, we concluded that the risk of developing H. pylori-associated diseases varies among different geographic populations despite living simultaneously in the same country.

The “Asian paradox” might be explained by the widespread prevalence of weakly cytotoxic strains and correspondingly low frequency of H. pylori-associated diseases. However, here, the prevalence of strains with the vacA s1 region among Southeast Asia populations was similar to that of East Asian and Latin American populations, who have a higher risk of gastric carcinogenesis [7, 9, 10]; half of the isolated H. pylori strains were Western-type strains with an EPIYA-ABC genotype. The sequence of the EPIYA-D type perfectly matches the high-affinity binding sequence for SHP2 domains of SHP-2 (pY-[V/T/A/I/S]-X-[L/I/V]-X-[F/W]) [51, 52]. In contrast, the sequences of the EPIYA-C type differ from the SHP-2 binding sequence by a single amino acid located in the pY + 5th position [51, 52]. As a result, East Asian-type CagA exhibits stronger binding activity for SHP-2 and a greater ability to induce morphological changes in epithelial cells than the Western type. The estimated age-standardized incidence rates of gastric cancer in Vietnamese patients (24.4 and 14.6/100,000 in men and women, respectively) infected with East Asian-strains of H. pylori are relatively higher than those in Thailand (4.2 and 3.0/100,000 in men and women, respectively) and Malaysia (10.7 and 6.4/100,000), where the majority of the population is Thai and Malay, and are infected with Western-type strains (http://globocan.iarc.fr/). Therefore, the lower prevalence of higher virulence strains (e.g., ABD type) may explain the low frequency of gastric cancer observed in Southeast Asia, particularly in the southern part.

In Vietnam, H. pylori infection was detected at a rate of approximately 66% and was shown to be strongly associated with active gastritis, atrophy and intestinal metaplasia [33]. As genetic characteristics of H. pylori in Vietnam, the majority of isolates possess cagA, oipA “on”, vacA s1, and vacA i1 genes, while the incidence of vacA m1 gene is less frequent [7, 31, 33]. Here, the prevalence of the vacA m1 genotype in patients residing in Hanoi and Ho Chi Minh were 58% and 34%, respectively. The prevalence of peptic ulcer disease in Hanoi, located in the northern part of Vietnam, is significantly higher than that in the southern city of Ho Chi Minh, despite similarities of ethnicity and diet [33]. Moreover, the age-standardized incidence rate of gastric cancer in Hanoi was approximately 1.5-fold higher than that in Ho Chi Minh (27.0 vs. 18.7 cases per 100,000 males, respectively) [33]. The higher prevalence of peptic ulcer disease and gastric cancer observed in Hanoi might be attributable to the higher prevalence of H. pylori strains carrying vacA m1 in this region. Although Vietnam is located between regions with a high and low risk of gastric cancer, the rate of gastric cancer in Vietnam is approximately three times lower than that in Japan and Korea, a finding that might also explain the low prevalence of H. pylori strains carrying vacA m1 (58% vs. nearly 100% in East Asia) [7, 16, 53].

Thailand has a population of 60 million people and is comprised of two major ethnic groups: Thai and Chinese. Eight types of H. pylori strains were identified in Thailand; half of the strains possessed genotypes typically found in South Asia (cagA type 2a/cag right-end junction type III and vacA s1a-m1c), while the other half consisted of genotypes typically encountered in East Asia (cagA type 1a/cag right-end junction type II and vacA s1c-m1b) based on combinations of cagA EPIYA motif genotype, genotype at the right end of the cag pathogenicity island into five subtypes according to deletion, insertion and substitution motifs (e.g., Type II strains were predominant in China and Japan and type III strains were most common in India and type III strains were typical of strains from India) and vacA s-region genotype [7, 54]. Thailand was considered to be a cross roads with respect to H. pylori genotypes, as isolates from ethnic Thai were commonly either South/Central Asian or mixed genotypes (East Asian and South/Central Asian) based on the cagA, cagPAI, and vacA genes, whereas isolates from ethnic Chinese were typically the East-Asian genotype [55]. Although the incidence of gastric cancer in Thailand is lower than that of East-Asian populations, the incidence of gastric cancer is not rare among Chinese living in Thailand, as the majority of gastric cancers (82%) occurred among ethnic Chinese or Thai-Chinese. Therefore, the incidence of gastric cancer varies among different geographic populations, and the high prevalence of higher-virulence strains may be associated with the high frequency of gastric cancer in Chinese residing in Thailand, which is typically a low-incidence area.

In Malaysia, three distinct ethnic groups predominate: Malays, Chinese, and Indians. Chinese and Indians have migrated to Malaysia for nearly three consecutive generations. The vacA s1c genotype was also the predominant genotype detected among the Chinese patients residing in Malaysia, while s1a was predominant in Indians and Malays in Kuala Lumpur [37].

The present study has some limitations. First, in this study, because the prevalence of cagA-negative strains was very low in Southeast Asian countries, we did not demonstrate the relationship between risk of H. pylori-related diseases and cagA-negative strains, which are 20-80% of H. pylori strains isolated from US and European population. Second, there was no information about biochemical role among different H. pylori virulent factors (e.g., cagA status, cagA EPIYA motif and vacA genotypes) in pathogenesis for peptic ulcer disease and gastric cancer development [56]. Recently, Mueller, et al. [56] reported association of c-Src and c-Abl kinases and phosphorylation of EPIYA motif, and differences of phosphorylation between East Asian-type strain (EPIYA-ABD) and Western type strain (EPIYA-ABC). Therefore, further studies will be required to clarify the role of H. pylori cagA EPIYA motif and vacA genotype for the development of gastrointestinal diseases.

Conclusion

We demonstrated that the prevalence of specific vacA m-region and cagA EPIYA motif genotypes was found to vary significantly among the respective Southeast Asian countries. Moreover, our present meta-analyses identified a significant relationship between vacA m-region genotype and cagA status and the development of diseases in Southeast Asian. Importantly, most of the H. pylori strains isolated from countries with high incidences of gastric cancer concurrently possessed virulent genotypes such as vacA s1/m1 and East Asian-type cagA[7]. In contrast, in countries with a low gastric cancer incidence, such as Thailand and Malaysia, a considerable proportion of H. pylori isolates exhibited less virulent genotypes, such as vacA m2 and Western-type cagA[7]. Based on the age-standardized incidence rate of gastric cancer, Asian countries can be categorized as either high-risk (e.g., Japan, Korea, and China), intermediate-risk (e.g., Vietnam), or low-risk (e.g., Thailand and Indonesia). The clinical usefulness of cagA EPIYA motif and vacA genotype testing must be evaluated in studies using a large number of individuals with cagA EPIYA motif and vacA genotypes.

Author contributions

SS, MS, R-KV, VM, HM, TF, and YY designed and performed research; SS and MS analyzed data and wrote the paper. All authors read and approved the final manuscript.

Disclosure

The authors declare that there are no conflicts of interest with regard to this work.

Grant support

A grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23590913).

Abbreviations

CI:

Confidence intervals

H. pylori :

Helicobacter pylori

NUD:

Non-ulcer dyspepsia

OR:

Odds ratios

PCR:

Polymerase chain reaction.

References

  1. 1.

    Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001, 345 (11): 784-789. 10.1056/NEJMoa001999.

  2. 2.

    Hopkins RJ, Girardi LS, Turney EA: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996, 110 (4): 1244-1252. 10.1053/gast.1996.v110.pm8613015.

  3. 3.

    Wotherspoon AC, Doglioni C, De Boni M, Spencer J, Isaacson PG: Antibiotic treatment for low-grade gastric malt lymphoma. Lancet. 1994, 343 (8911): 1503-10.1016/S0140-6736(94)92613-1.

  4. 4.

    Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008, 372 (9636): 392-397. 10.1016/S0140-6736(08)61159-9.

  5. 5.

    Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, Echeverria PD, Blaser MJ: Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis. 1990, 161 (6): 1237-1241. 10.1093/infdis/161.6.1237.

  6. 6.

    Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT, Mendes CC, Lima Junior GF, Oliveira CA: Indirect immunofluorescence determination of the frequency of anti-H pylori antibodies in brazilian blood donors. Braz J Med Biol Res. 1992, 25 (7): 683-689.

  7. 7.

    Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, et al: Helicobacter pylori in north and south america before columbus. FEBS Lett. 2002, 517 (1–3): 180-184.

  8. 8.

    Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, De Boer WA: Importance of Helicobacter pylori caga and vacA status for the efficacy of antibiotic treatment. Gut. 2000, 46 (3): 321-326. 10.1136/gut.46.3.321.

  9. 9.

    Sugimoto M, Yamaoka Y: The association of vacA genotype and Helicobacter pylori-related disease in latin american and african populations. Clin Microbiol Infect. 2009, 15 (9): 835-842. 10.1111/j.1469-0691.2009.02769.x.

  10. 10.

    Sugimoto M, Zali MR, Yamaoka Y: The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis. 2009, 28 (10): 1227-1236. 10.1007/s10096-009-0772-y.

  11. 11.

    Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T, Yamada N: Genetic differences in interleukin-1 beta polymorphisms among four asian populations: an analysis of the Asian paradox between h. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res. 2003, 22 (1): 47-55.

  12. 12.

    Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N: Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in thais. J Gastroenterol. 2006, 41 (12): 1169-1177.

  13. 13.

    Lunet N, Barros H: Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003, 106 (6): 953-960. 10.1002/ijc.11306.

  14. 14.

    Miwa H, Go MF, N S: H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002, 97 (5): 1106-1112. 10.1111/j.1572-0241.2002.05663.x.

  15. 15.

    Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY: Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999, 37 (7): 2274-2279.

  16. 16.

    Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY: Importance of Helicobacter pylori oipa in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002, 123 (2): 414-424. 10.1053/gast.2002.34781.

  17. 17.

    Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science. 1999, 284 (5418): 1328-1333. 10.1126/science.284.5418.1328.

  18. 18.

    Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M: Shp-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science. 2002, 295 (5555): 683-686. 10.1126/science.1067147.

  19. 19.

    Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F: Risk factors for failure of Helicobacter pylori therapy–results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther. 2003, 17 (1): 99-109. 10.1046/j.1365-2036.2003.01396.x.

  20. 20.

    van der Hulst RW, Weel JF, Verheul SB, Keller JJ, ten Kate FJ, van der Ende A, Rauws EA, Dankert J, Tytgat GN: Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther. 1996, 10 (2): 165-171. 10.1046/j.1365-2036.1996.715895000.x.

  21. 21.

    Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, Kashima K, Graham DY: Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999, 117 (2): 342-349. 10.1053/gast.1999.0029900342.

  22. 22.

    Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M: Biological activity of the Helicobacter pylori virulence factor cagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002, 99 (22): 14428-14433. 10.1073/pnas.222375399.

  23. 23.

    Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src is the kinase of the Helicobacter pylori caga protein in vitro and in vivo. J Biol Chem. 2002, 277 (9): 6775-6778. 10.1074/jbc.C100754200.

  24. 24.

    Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF: Phosphorylation of tyrosine 972 of the Helicobacter pylori cagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001, 42 (3): 631-644.

  25. 25.

    Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995, 270 (30): 17771-17777. 10.1074/jbc.270.30.17771.

  26. 26.

    Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007, 133 (3): 926-936. 10.1053/j.gastro.2007.06.056.

  27. 27.

    Kidd M, Lastovica AJ, Atherton JC, Louw JA: Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut. 1999, 45 (4): 499-502. 10.1136/gut.45.4.499.

  28. 28.

    Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdorffer E: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in germany. Int J Cancer. 2000, 87 (3): 322-327. 10.1002/1097-0215(20000801)87:3<322::AID-IJC3>3.0.CO;2-M.

  29. 29.

    Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F: Helicobacter pylori genotypes are associated with clinical outcome in portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001, 36 (2): 128-135.

  30. 30.

    Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ: Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997, 112 (1): 92-99. 10.1016/S0016-5085(97)70223-3.

  31. 31.

    Uchida T, Nguyen LT, Takayama A, Okimoto T, Kodama M, Murakami K, Matsuhisa T, Trinh TD, Ta L, Ho DQ, et al: Analysis of virulence factors of Helicobacter pylori isolated from a vietnamese population. BMC Microbiol. 2009, 9: 175-10.1186/1471-2180-9-175.

  32. 32.

    Truong BX, Mai VT, Tanaka H, le Ly T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, et al: Diverse characteristics of the cagA gene of Helicobacter pylori strains collected from patients from South Vietnam with gastric cancer and peptic ulcer. J Clin Microbiol. 2009, 47 (12): 4021-4028. 10.1128/JCM.00504-09.

  33. 33.

    Nguyen TL, Uchida T, Tsukamoto Y, Trinh DT, Ta L, Mai BH, Le SH, Thai KD, Ho DD, Hoang HH, et al: Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol. 2010, 10: 114-10.1186/1471-230X-10-114.

  34. 34.

    Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004, 9 (5): 453-459. 10.1111/j.1083-4389.2004.00260.x.

  35. 35.

    Linpisarn S, Suwan W, Lertprasertsuk N, Koosirirat C, Steger HF, Prommuangyong K, Phornphutkul K: Helicobacter pylori cagA, vacA and iceA genotypes in Northern Thai patients with gastric disease. Southeast Asian J Trop Med Public Health. 2007, 38 (2): 356-362.

  36. 36.

    Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, Tor-Udom S, Vilaichone RK: Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and baba2 genotypes in thai dyspeptic patients. Int J Infect Dis. 2008, 12 (1): 30-36. 10.1016/j.ijid.2007.03.012.

  37. 37.

    Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia. J Gastroenterol Hepatol. 2005, 20 (4): 589-594. 10.1111/j.1440-1746.2005.03783.x.

  38. 38.

    Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. J Gastroenterol Hepatol. 2006, 21 (1 Pt 1): 110-115.

  39. 39.

    Mohamed R, Hanafiah A, Rose IM, Manaf MR, Abdullah SA, Sagap I, Van Belkum A, Yaacob JA: Helicobacter pylori cagA gene variants in malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis. 2009, 28 (7): 865-869. 10.1007/s10096-009-0712-x.

  40. 40.

    Schmidt HM, Goh KL, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H: Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter. 2009, 14 (4): 256-263. 10.1111/j.1523-5378.2009.00684.x.

  41. 41.

    Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L, Goh KL, Fock KM, Forman D, Mitchell H: The cagA PAI is intact and functional but hp0520 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis. 2010, 29 (4): 439-451. 10.1007/s10096-010-0881-7.

  42. 42.

    Zheng PY, Hua J, Yeoh KG, Ho B: Association of peptic ulcer with increased expression of lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000, 47 (1): 18-22. 10.1136/gut.47.1.18.

  43. 43.

    Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W: Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998, 115 (1): 58-66. 10.1016/S0016-5085(98)70365-8.

  44. 44.

    Ho YW, Ho KY, Ascencio F, Ho B: Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J Gastroenterol. 2004, 10 (22): 3274-3277.

  45. 45.

    Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L: Prevalence of cagA and vacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004, 87 (11): 1327-1331.

  46. 46.

    Yamaoka Y, Malaty HM, Osato MS, Graham DY: Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000, 181 (6): 2083-2086. 10.1086/315486.

  47. 47.

    Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y: Role of deletion located between intermediate- and middle-region of Helicobacter pylori vacA gene in gastroduodenal diseases. J Clin Microbiol. 2009, 47 (11): 3493-3500. 10.1128/JCM.00887-09.

  48. 48.

    Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, et al: Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001, 158 (2): 647-654. 10.1016/S0002-9440(10)64006-0.

  49. 49.

    Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpcao MB, Vilar SC, Freitas FB, Barbosa HP, Fecury AA, do Amaral RK: Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from north brazil. Mem Inst Oswaldo Cruz. 2005, 100 (8): 875-881. 10.1590/S0074-02762005000800009.

  50. 50.

    Breurec S, Guillard B, Hem S, Brisse S, Dieye FB, Huerre M, Oung C, Raymond J, Tan TS, Thiberge JM, et al: Evolutionary history of Helicobacter pylori sequences reflect past human migrations in Southeast Asia. PLoS One. 2011, 6 (7): e22058-10.1371/journal.pone.0022058.

  51. 51.

    Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T, Hatakeyama M: EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor cagA in mammalian cells. J Biol Chem. 2005, 280 (24): 23130-23137. 10.1074/jbc.M503583200.

  52. 52.

    Hatakeyama M: Oncogenic mechanisms of the Helicobacter pylori cagA protein. Nat Rev Cancer. 2004, 4 (9): 688-694. 10.1038/nrc1433.

  53. 53.

    Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006, 55 (6): 775-781. 10.1136/gut.2005.083014.

  54. 54.

    Kersulyte D, Mukhopadhyay AK, Velapatino B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, et al: Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol. 2000, 182 (11): 3210-3218. 10.1128/JB.182.11.3210-3218.2000.

  55. 55.

    Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand J Gastroenterol. 2005, 40 (5): 530-539. 10.1080/00365520510012299.

  56. 56.

    Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S: C-src and c-abl kinases control hierarchic phosphorylation and function of the cagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012, 122 (4): 1553-1566. 10.1172/JCI61143.

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/223/prepub

Download references

Acknowledgments

We thank Dr. Takahiro Uotani, Dr. Mihoko Yamade, Dr. Hitomi Ichikawa and Dr. Ken Sugimoto for their helpful comments. This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23590913).

Author information

Affiliations

  1. First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

    • Shu Sahara
    • , Mitsushige Sugimoto
    •  & Hiroaki Miyajima

  2. Gastroenterology Unit, Department of Medicine, Thammasat University Hospital, Pathumthani, Thailand

    • Ratha-Korn Vilaichone

  3. Gastroenterology Unit, Department of Medicine, Chulalongkorn University Hospital, Bangkok, Thailand

    • Varocha Mahachai

  4. Center for Clinical Research, Hamamatsu University School of Medicine, Hamamatsu, Japan

    • Takahisa Furuta

  5. Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, Yufu, Japan

    • Yoshio Yamaoka

Authors

  1. Search for Shu Sahara in:

  2. Search for Mitsushige Sugimoto in:

  3. Search for Ratha-Korn Vilaichone in:

  4. Search for Varocha Mahachai in:

  5. Search for Hiroaki Miyajima in:

  6. Search for Takahisa Furuta in:

  7. Search for Yoshio Yamaoka in:

Corresponding author

Correspondence to Mitsushige Sugimoto.

Additional information

Competing interests

The authors declare no competing interests related to this study.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Sahara, S., Sugimoto, M., Vilaichone, R. et al. Role of Helicobacter pylori cagA EPIYA motif and vacAgenotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis. BMC Infect Dis 12, 223 (2012) doi:10.1186/1471-2334-12-223

Download citation

Keywords

  • Helicobacter pylori
  • cagA
  • vacA
  • EPIYA
  • Gastric cancer
  • Peptic ulcer disease
  • Southeast Asian

BMC Infectious Diseases

ISSN: 1471-2334

Contact us